Legal status · Canada
Is Anti-IL-11 legal in Canada?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. Anti-IL-11 is not approved for any medical use in Canada; its classification is "Investigational, not approved". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. On the evidence, no human study is cited on its profile.
Anti-IL-11 in Canada at a glance
| Classification | Investigational, not approved |
|---|---|
| Health Canada approval status | Not approved by Health Canada; investigational |
| Human studies cited | 0 of 1 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Anti-IL-11 profile, checked against Health Canada, Health Products and Food Branch (Health Canada) listings at the reviewed date.
What this means
- 01
Anti-IL-11 is being studied in registered clinical trials but has not received Health Canada marketing approval in Canada.
- 02
Lawful human access is limited to trial participation or a formal early-access scheme where one exists; there is no pharmacy product to prescribe.
- 03
Vials sold online "for research use only" are not trial material, and that label does not make human use lawful.
What Anti-IL-11 is
Blocking a single inflammatory cytokine extended healthspan and lifespan in mice, and it worked when started in already old animals. No human ageing trial exists.
This is one of the more striking mouse results in recent ageing biology, and the detail that matters is when treatment started. Interleukin-11 is a cytokine in the interleukin-6 family that rises with age and drives fibrosis and inflammatory signalling.
Mechanism: Interleukin-11 signals through a receptor complex using IL-11RA and the shared gp130 subunit, activating JAK and STAT3 and also ERK signalling. It is a driver of fibroblast activation and fibrosis across organs, and its expression rises with age.
Regulatory history: No anti-IL-11 agent is approved for any indication. Recombinant IL-11 itself, oprelvekin, was previously an approved drug for thrombocytopenia, which is the opposite intervention.
How Health Canada treats this kind of product
Authorises drugs for sale through a Notice of Compliance and Drug Identification Number. A compound that is not authorised for sale cannot lawfully be sold for human use, and personal importation of prescription drugs is limited.
The classification above is the The Longevity Archive reading of Health Canada, Health Products and Food Branch listings for Anti-IL-11 at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Anti-IL-11 in other countries
Frequently asked questions
Is Anti-IL-11 legal in Canada?
No. Anti-IL-11 is not approved for any medical use in Canada; its classification is "Investigational, not approved". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. On the evidence, no human study is cited on its profile.
Can I buy Anti-IL-11 in Canada?
No approved product exists to buy. In Canada Anti-IL-11 is classified as "Investigational, not approved", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.
Is Anti-IL-11 Health Canada approved?
No. In Canada Anti-IL-11 is classified as "Investigational, not approved", which is not a Health Canada marketing approval. For comparison, the US FDA status is: No anti-IL-11 agent is approved for any indication. Recombinant IL-11 itself, oprelvekin, was previously an approved drug for thrombocytopenia, which is the opposite intervention.. On the evidence, no human study is cited on its profile.
Related compounds in Canada
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Anti-IL-11 live on its compound profile.
Anti-IL-11 profileThis page is general information about the regulatory status of Anti-IL-11 in Canada, current as of Sep 2026. It is not legal advice, and classifications change; check Health Canada, Health Products and Food Branch directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.